NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea · Delayed Price · Currency is KRW 603.00
+45.00 (8.06%)
Nov 20, 2025, 3:30 PM KST
NeoImmuneTech Revenue
NeoImmuneTech had revenue of 18.33M KRW in the quarter ending September 30, 2025, a decrease of -86.13%. This brings the company's revenue in the last twelve months to 94.29M, down -28.64% year-over-year. In the year 2024, NeoImmuneTech had annual revenue of 170.38M.
Revenue (ttm)
94.29M
Revenue Growth
-28.64%
P/S Ratio
585.10
Revenue / Employee
1.81M
Employees
52
Market Cap
55.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 170.38M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.59T |
| Hyundai Motor Company | 186.04T |
| Kia Corporation | 111.04T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Hanwha Aerospace | 19.25T |
| Doosan Enerbility | 16.30T |
| HD Hyundai Heavy Industries | 15.58T |